We are live on ! Find out more
KRTX

Karuna Therapeutics, Inc. Common Stock
KRTX

Delisted

KRTX was delisted on the 15th of March, 2024.

Back to rankings

2 hedge funds and large institutions have $270K invested in Karuna Therapeutics, Inc. Common Stock in 2024 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 325 closing their positions.

New
Increased
Maintained
Reduced
Closed

99% less funds holding

Funds holding: 328 → 2 (-326)

100% less funds holding in top 10

Funds holding in top 10: 26 → 0 (-26)

100% less capital invested

Capital invested by funds: $12B → $270K (-$12B)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 325

100% less repeat investments, than reductions

Existing positions increased: 0 | Existing positions reduced: 1

Holders
2
Holders Change
-326
Holders Change %
-99.39%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
-26
Holding in Top 10 Change %
-100%
% of All Funds
–
New
–
Increased
–
Reduced
1
Closed
325
Calls
$2K
Puts
–
Net Calls
+$2K
Net Calls Change
-$46.5M

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Capital International Investors
Capital International Investors
California
-$1.34B
2
Vanguard Group
Vanguard Group
Pennsylvania
-$1.02B
3
Fidelity Investments
Fidelity Investments
Massachusetts
-$907M
4
T. Rowe Price Investment Management
T. Rowe Price Investment Management
Maryland
-$858M
5
BlackRock
BlackRock
New York
-$638M
Name Holding Trade Value Shares
Change 		Change in
Stake
Swiss National Bank
76
Swiss National Bank
Switzerland
– -$20M -63,100 Closed
PSAMP
77
P. Schoenfeld Asset Management (PSAM)
New York
– -$19.9M -63,000 Closed
Fidelity International
78
Fidelity International
Bermuda
– -$19M -59,885 Closed
Deutsche Bank
79
Deutsche Bank
Germany
– -$18.6M -58,632 Closed
Neuberger Berman Group
80
Neuberger Berman Group
New York
– -$18.5M -58,503 Closed
CS
81
Candriam SCA
Luxembourg
– -$18.1M -57,201 Closed
PMAM
82
Picton Mahoney Asset Management
Ontario, Canada
– -$17.4M -55,000 Closed
MB
83
MPM BioImpact
Massachusetts
– -$16.9M -53,279 Closed
Dimensional Fund Advisors
84
Dimensional Fund Advisors
Texas
– -$16.4M -51,891 Closed
California Public Employees Retirement System
85
California Public Employees Retirement System
California
– -$16M -50,696 Closed
NNPTE
86
Nationale-Nederlanden Powszechne Towarzystwo Emerytalne
Poland
– -$16M -50,400 Closed
MAM
87
Melqart Asset Management
United Kingdom
– -$15.9M -50,194 Closed
RHJA
88
Rice Hall James & Associates
California
– -$15.9M -50,171 Closed
DCM
89
DAFNA Capital Management
California
– -$15.2M -48,145 Closed
SPPAM
90
Summit Partners Public Asset Management
Massachusetts
– -$15.2M -47,910 Closed
RhumbLine Advisers
91
RhumbLine Advisers
Massachusetts
– -$14.9M -47,175 Closed
DC
92
Decheng Capital
California
– -$14.9M -47,000 Closed
American Century Companies
93
American Century Companies
Missouri
– -$14.3M -45,064 Closed
Rafferty Asset Management
94
Rafferty Asset Management
New York
– -$13.8M -43,693 Closed
State Board of Administration of Florida Retirement System
95
State Board of Administration of Florida Retirement System
Florida
– -$13.5M -42,548 Closed
Connor, Clark & Lunn Investment Management (CC&L)
96
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
– -$13.4M -42,289 Closed
Ameriprise
97
Ameriprise
Minnesota
– -$13.4M -42,221 Closed
GF
98
Gabelli Funds
New York
– -$13.3M -42,000 Closed
N
99
Natixis
France
– -$13.2M -41,737 Closed
Hudson Bay Capital Management
100
Hudson Bay Capital Management
Connecticut
– -$12.7M -40,000 Closed
2 3
4
5 6

KRTX Hedge Fund Activity: Q1 2024 in Review

2 of the 6,943 institutional investors tracked by Wall St. Rank reported a position in Karuna Therapeutics, Inc. Common Stock (KRTX) for Q1 2024, worth a combined $270K — down 100% from $12B a quarter earlier.

Sellers outnumbered buyers: 325 funds closed out of KRTX and 0 opened new positions — a net loss of 325 holders — while 1 trimmed existing stakes and 0 added.

The largest seller was Capital International Investors, exiting entirely with an estimated $1.34B sold.

  • 2 institutional investors held Karuna Therapeutics, Inc. Common Stock (KRTX) as of Q1 2024, down from 328 in Q4 2023.
  • Funds reported $270K of Karuna Therapeutics, Inc. Common Stock stock for Q1 2024, down 100% quarter-over-quarter.
  • 0 funds opened new Karuna Therapeutics, Inc. Common Stock positions in Q1 2024 and 325 closed out, a net change of -325 holders.
  • The largest Karuna Therapeutics, Inc. Common Stock seller in Q1 2024 was Capital International Investors, an estimated $1.34B sold.

Based on aggregated 13F filings for Q1 2024.